Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
Journal: Neuro-oncology advances
Published: December 30, 2024
Development of a non-invasive bioassay for adiponectin target engagement in mice.
Journal: iScience
Published: June 11, 2024
The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.mdx mouse model of Duchenne muscular dystrophy.
Journal: American journal of physiology. Cell physiology
Published: December 25, 2023
A novel blood-based bioassay to monitor adiponectin signaling.
Journal: International immunopharmacology
Published: December 02, 2023
Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF).
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 29, 2023
The adiponectin-derived peptide ALY688 protects against the development of metabolic dysfunction-associated steatohepatitis.
Journal: Clinical and translational science
Published: August 11, 2023
Phase Ⅰ/Ⅱ, Double-Masked, Randomized, Vehicle-Controlled Study of H-1337 Ophthalmic Solution for Glaucoma and Ocular Hypertension.
Journal: Ophthalmology. Glaucoma
Published: March 18, 2022
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden.
Journal: Future oncology (London, England)
Published: January 18, 2022
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2021
Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 01, 2020
Long-term outcomes of pexidartinib in tenosynovial giant cell tumors.
Journal: Cancer
Published: August 07, 2020
Last Updated: 09/26/2026